Womed Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Crowdfunding
- (Announced)
- Latest Deal Amount
-
$2.66M
- Investors
-
6
Womed General Information
Description
Developer of intrauterine treatments intended to address uterine health conditions. The company develops biomaterial-based medical devices and localized drug delivery treatments for intrauterine adhesions, infertility, fibroids, endometriosis, and acute uterine bleeding, enabling healthcare providers to treat uterine disorders with targeted, minimally invasive therapies.
Contact Information
Website
www.womedtech.comCorporate Office
- 1919 route de Mende
- Batiment Balard - CIT
- 34090 Montpellier
- France
Corporate Office
- 1919 route de Mende
- Batiment Balard - CIT
- 34090 Montpellier
- France
Womed Timeline
Womed Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Equity Crowdfunding | 23-Apr-2026 | $2.66M | Announced | Generating Revenue | ||
| 6. Later Stage VC | 17-Jul-2026 | Completed | Generating Revenue | |||
| 5. Grant | 08-Nov-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 31-Oct-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2022 | Completed | Startup | |||
| 2. Angel (individual) | 26-Nov-2019 | $1.22M | $1.22M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Womed Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Womed Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Womed Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Womed Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Cantrak | Family Office | Minority | ||
| Cemag Invest | Family Office | Minority | ||
| IRDI Capital Investissement | PE/Buyout | Minority | ||
| Neighborhood | Accelerator/Incubator |
Womed FAQs
-
When was Womed founded?
Womed was founded in 2018.
-
Where is Womed headquartered?
Womed is headquartered in Montpellier, France.
-
What is the size of Womed?
Womed has 10 total employees.
-
What industry is Womed in?
Womed’s primary industry is Surgical Devices.
-
Is Womed a private or public company?
Womed is a Private company.
-
What is Womed’s current revenue?
The current revenue for Womed is .
-
How much funding has Womed raised over time?
Womed has raised $13.3M.
-
Who are Womed’s investors?
European Innovation Council, Cantrak, Cemag Invest, IRDI Capital Investissement, and Neighborhood are 5 of 6 investors who have invested in Womed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
